Pharmaceutical Supply and Distribution

The contract entails the manufacture and supply of FDA-approved Nitroglycerin Lingual Aerosol as a commercial off-the-shelf pharmaceutical product, ensuring full compliance with current Good Manufacturing Practices, Drug Enforcement Administration regulations, and Defense Logistics Agency National Stock Number packaging standards. The product is intended for distribution through military and defense healthcare channels, requiring rigorous quality control, secure handling, and adherence to federal pharmaceutical and logistical protocols to maintain efficacy and regulatory legitimacy throughout the supply chain. The agreement is structured as a subcontract under the Department of Defense, specifically managed by the Defense Logistics Agency, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing. The contract was posted on August 1, 2026, and is tied to the procurement system with the contract number SPE2DX25D8022 and delivery identifier SPE2D926F7840. All production and packaging must meet exacting federal standards to support deployment in military medical settings, and the supplier is responsible for end-to-end compliance, from formulation and labeling to distribution readiness, without customization or deviation from the approved commercial product specifications.